Janus Henderson Investors US’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Janus Henderson Investors US’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,200	Closed	-$243K	–	1239
2016 Q3	$243K	Buy	+2,200	New	+$291K	﹤0.01%	1190
2015 Q2	–	Sell	-9,474	Closed	-$1.34M	–	1142
2015 Q1	$1.34M	Sell	9,474 -20,407	-68%	-$3.14M	﹤0.01%	927
2014 Q4	$4.43M	Sell	29,881 -5,056	-14%	-$743K	﹤0.01%	813
2014 Q3	$5.38M	Sell	34,937 -21,869	-38%	-$3.29M	﹤0.01%	772
2014 Q2	$7.97M	Buy	56,806 +41,455	+270%	+$4.6M	0.01%	718
2014 Q1	$1.7M	Buy	15,351 +4,788	+45%	+$521K	﹤0.01%	890
2013 Q4	$1.04M	Hold	10,563	–	–	﹤0.01%	919
2013 Q3	$803K	Buy	+10,563	New	+$685K	﹤0.01%	941

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Investors US's TARO Position: Q4 2016 in Review

Janus Henderson Investors US sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 2,200 shares — an estimated $243K sold.

Janus Henderson Investors US first reported a position in TARO in Q3 2013 and held it in 8 quarters. The position peaked at $7.97M in Q2 2014. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

Janus Henderson Investors US reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
Janus Henderson Investors US sold 2,200 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $243K.
Janus Henderson Investors US first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 8 quarters.
Janus Henderson Investors US's Taro Pharmaceutical Industries Ltd. position peaked at $7.97M in Q2 2014.
151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Janus Henderson Investors US's 13F filing for Q4 2016, filed 14 Feb 2017.